SCHEMBL21632829

SCHEMBL21632829

CNCCC(Oc1ccccc1NC(=O)CN1CCC(c2cccc(O)c2)CC1)c1ccccc1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ DRD4 P21917 4/20 0.51
▸ DRD2 P14416 3/20 0.45
▸ DRD3 P35462 3/20 0.45
▸ CYP2D6 P10635 5/20 0.43
▸ CYP2C19 P33261 2/20 0.43
▸ KDM4E B2RXH2 1/20 0.43
▸ KMT2A Q03164 4/20 0.42
▸ ALDH1A1 P00352 2/20 0.42
▸ SLC6A4 P31645 5/20 0.41
▸ SLC6A2 P23975 4/20 0.41
▸ CYP1A2 P05177 4/20 0.41
▸ CYP3A4 P08684 4/20 0.41
▸ TSHR P16473 4/20 0.41
▸ SLC6A3 Q01959 3/20 0.41
▸ CHRM1 P11229 2/20 0.41
▸ ADRA2B P18089 2/20 0.41
▸ HTR2A P28223 2/20 0.41
▸ HTR2C P28335 2/20 0.41
▸ HRH1 P35367 2/20 0.41
▸ OPRM1 P35372 2/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21632814 0.92 PRCP (0.49) DRD4DRD2DRD3L3MBTL1
SCHEMBL21633034 0.89 DRD4 (0.49) DRD4DRD2DRD3CYP2D6CYP2C19
SCHEMBL21633032 0.88 DRD4 (0.49) DRD4DRD2DRD3CYP2D6CYP2C19
SCHEMBL21633140 0.86 DRD2 (0.47) DRD4DRD2DRD3CYP2D6CYP2C19
SCHEMBL21658581 0.83 DRD2 (0.51) DRD4DRD2DRD3CYP2D6CYP2C19
SCHEMBL21632830 0.81 SLC6A3 (0.47) DRD4DRD2DRD3CYP2D6CYP2C19
SCHEMBL21061343 0.76 SLC6A2 (0.43) DRD3CYP2D6CYP2C19KDM4EKMT2A
SCHEMBL21632833 0.73 ACHE (0.51) DRD4DRD3CYP2D6CYP2C19KMT2A
SCHEMBL21633001 0.72 SLC6A2 (0.49) DRD3CYP2D6CYP2C19KDM4EKMT2A
SCHEMBL21118566 0.72 SLC6A2 (0.56) DRD3CYP2D6CYP2C19KMT2AALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2020021021-A1 ORTHO SUBSTITUTED PHENOXYPROPYLAMINO AND BENZYLOXYPROPYLAMINO DERIVATIVES HAVING MULTIMODAL ACTIVITY AGAINST PAIN ESTEVE PHARMACEUTICALS, S.A. (ES) 2020-01-30 — — WO claimed
WO-2020021021-A1 ORTHO SUBSTITUTED PHENOXYPROPYLAMINO AND BENZYLOXYPROPYLAMINO DERIVATIVES HAVING MULTIMODAL ACTIVITY AGAINST PAIN ESTEVE PHARMACEUTICALS, S.A. (ES) 2020-01-30 — — WO disclosed
WO-2020021021-A1 ORTHO SUBSTITUTED PHENOXYPROPYLAMINO AND BENZYLOXYPROPYLAMINO DERIVATIVES HAVING MULTIMODAL ACTIVITY AGAINST PAIN ESTEVE PHARMACEUTICALS, S.A. (ES) 2020-01-30 — — WO disclosed
Send feedback